This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders USA
New Data, Case Studies & Partners
September 10th-11th, 2025Boston Exhibition & Convention Center, USA

Paris Aliahmad
Head of Research and Development at Replicate Bioscience
Speaker

Profile

Dr. Parinaz (Paris) Aliahmad is Head of Research and Development at Replicate Bioscience. She has expertise in drug development, including both small molecules therapeutics and vaccines (inclusive of nucleic acid, protein, and viral vector-based platforms) and comprehensive knowledge of the immune system as it relates to establishing host immunity with vaccines and immunotherapies, as well dampening inflammation in autoimmune disease.

Prior to Replicate Bioscience, Dr. Aliahmad has held positions at both Janssen and Synthetic Genomics, leading translational studies of a self-replicating RNA platform asset for infectious disease and oncology vaccines.

Dr. Aliahmad is an inventor on multiple patents for applications of synthetic biology and use of novel technologies for vaccines and therapeutics. She received a Ph.D. in Immunology from Scripps Research. Prior to this, she earned a M.S. in Immunology from the University of Toronto and a B.S. in Microbiology & Immunology from McGill University.

Agenda Sessions

  • Chair Opening Address: mRNA Therapeutics & Vaccines

    11:30am

At this event